Insider Transactions Reported by 11 Insiders of GT Biopharma, Inc.

Symbol
GTBP on Nasdaq
Location
San Francisco, CA

There are no Buy or Sell transactions made by insiders since 13 Feb 2025

GT Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Manu Ohri CFO & Secretary $100,450 11 Aug 2023
M.D. Gregory Berk Pres. of R&D, CMO $79,803 15 Jul 2022
Andrew J. Ritter Director 08 May 2025
Michael Martin Breen CEO and Director, Director 04 Sep 2025
Bruce Wendel Director 27 Jan 2023
Rajesh Shrotriya Director 27 Jan 2023
Gavin Choy Acting Chief Financial Officer 31 Dec 2021
CHARLES J. CASAMENTO Director 04 Sep 2025
Alan Urban Chief Financial Officer 04 Sep 2025
David C. Mun-Gavin Director 04 Sep 2025
Hilary Kramer Director 04 Sep 2025

Recent Insider Transactions by Companies or Individuals for GT Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.